Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of an intradermal inactivated split-virion influenza vaccine vs intramuscular Vaxigrip in the elderly
2006-002366-18Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Fluzone Intradermal in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Anti-hemagglutinin antibody titers at day 21. Started Jun 2006; status: completed.
02
Drugs
Fluzone Intradermal
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002366-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002366-18.